• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Food

  • Print
  • Share
  • E-mail

Section Contents Menu

News & Events

FDA to Convene a FSMA Public Meeting on International Capacity Building with Respect to Food Safety

Food Basket

Center for Food Safety and Applied Nutrition - Food and Drug Administration

May 18, 2012

The U.S. Food and Drug Administration (FDA) has announced a Food Safety Modernization Act (FSMA) Public Meeting on International Capacity Building with Respect to Food Safety. The meeting will be held on June 19, 2012, 9:00 am - 5:00 pm, at the L’Enfant Plaza Hotel, 480 L’Enfant Plaza, S.W., Washington, DC.

The purpose of the meeting is to provide interested persons an opportunity to discuss FDA’s comprehensive plan to expand the technical, scientific, and regulatory capacity of foreign governments and their respective food industries in countries that export foods to the United States (the “capacity-building plan”). FDA is developing this plan pursuant to FSMA. The public will have an opportunity to provide information and share views that will inform FDA’s development process.

Public Meeting attendees are encouraged to register on-line or contact: Courtney Treece, Planning Professionals, Ltd., 1210 W. McDermott, Suite 111, Allen, TX 75013, telephone: 704-258-4983, fax: 469-854-6992, e-mail: ctreece@planningprofessionals.com.

For general questions about the meeting or to request special accommodations due to a Disability, contact: Juanita Yates, FDA, Center for Food Safety and Applied Nutrition, telephone: 240-402-1731, e-mail: juanita.yates@fda.hhs.gov.

For additional information on capacity building, see International Capacity Building under FSMA.

Federal Register Notice of Public Meeting

Registration Online disclaimer icon

Please note the following important Dates:

  • June 11, 2012: Closing date for advance registration and requesting special accommodations due to a Disability
  • July 20, 2012: Closing date to submit either electronic or written comments to FDA’s Division of Dockets Management. Docket No. FDA-2012-N-0437